2009 FDA Globalization Act Scratches Fees For Cosmetics, “Unanticipated” AEs
This article was originally published in The Rose Sheet
The latest version of the FDA Globalization Act includes a number of changes beneficial to small cosmetic firms; however, the draft legislation still presents some overly burdensome requirements, according to Indie Beauty Network founder and CEO Donna Maria Coles Johnson, Esq
You may also be interested in...
Rep. Leonard Lance, R-N.J., introduces the Cosmetic Safety Amendments Act of 2012, with “the full support” of the Personal Care Products Council. Bill would not require manufacturers to substantiate product safety prior to market or pay user fees, but it does include registration, ingredient disclosure and adverse-event reporting requirements and proposes a significant increase in FDA’s oversight role.
A March 27 hearing titled “Examining the Current State of Cosmetics” will likely focus more on the future of cosmetics regulation in the U.S. CFSAN director Michael Landa is slated to testify, as are representatives from the Personal Care Products Council and small businesses.
Legislators may soon be considering two rival bills aimed at overhauling regulation of the cosmetics industry – the Safe Cosmetics Act of 2011 and separate legislation backed by the Personal Care Products Council.